Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03150693
Title Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

acute lymphoblastic leukemia

Therapies

Rituximab

Doxorubicin

Mercaptopurine

Methotrexate

Cyclophosphamide + Cytarabine

Thioguanine

Allopurinol

Daunorubicin

Dexamethasone

Vincristine Sulfate

Inotuzumab ozogamicin

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.